Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-21 07:54 am Unchanged |
2025-04-21 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
96,660,341 56.900% |
0 (Unchanged) |
Filing History |
| 2025-03-26 4:09 pm Purchase |
2025-03-19 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 9,500,000 5.590% |
8,500,000 (+850.00%) |
Filing History |
| 2025-03-07 10:01 am Purchase |
2025-02-28 | 13G | Immunovant, Inc. IMVT |
FMR LLC | 17,078,093 10.100% |
4,540,522 (+36.22%) |
Filing History |
| 2025-01-15 4:30 pm Purchase |
2025-01-13 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
96,660,341 56.900% |
16,845,010 (+21.10%) |
Filing History |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Immunovant, Inc. IMVT |
FMR LLC | 12,537,571 8.565% |
4,661,749 (+59.19%) |
Filing History |
| 2024-02-14 08:47 am Sale |
2023-12-31 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 1,000,000 0.690% |
-8,710,000 (-89.70%) |
Filing History |
| 2024-02-09 09:16 am Purchase |
2024-02-08 | 13G | Immunovant, Inc. IMVT |
FMR LLC | 7,875,822 5.444% |
7,875,822 (New Position) |
Filing History |
| 2023-10-04 5:19 pm Purchase |
2023-10-02 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
79,815,331 55.300% |
6,416,667 (+8.74%) |
Filing History |
| 2023-02-14 08:37 am Purchase |
2022-12-31 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 9,710,000 7.520% |
2,929,173 (+43.20%) |
Filing History |
| 2022-12-05 4:09 pm Sale |
2021-12-31 | 13G | Immunovant, Inc. IMVT |
RTW Investments, LP | 0 0.000% |
-8,459,241 (Position Closed) |
Filing History |
| 2022-12-02 4:06 pm Purchase |
2020-12-31 | 13G | Immunovant, Inc. IMVT |
RTW Investments, LP | 8,459,241 6.540% |
866,988 (+11.42%) |
Filing History |
| 2022-02-11 5:11 pm Purchase |
2022-02-04 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 6,780,827 5.830% |
6,780,827 (New Position) |
Filing History |
| 2021-08-02 08:23 am Purchase |
2021-08-02 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
73,398,664 63.800% |
17,021,276 (+30.19%) |
Filing History |
| 2021-03-08 08:00 am Unchanged |
2021-03-08 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
56,377,388 57.500% |
0 (Unchanged) |
Filing History |
| 2021-02-16 10:37 am Purchase |
2020-12-31 | 13G | Immunovant, Inc. IMVT |
RTW Investments, LP | 7,592,253 7.750% |
7,592,253 (New Position) |
Filing History |
| 2020-09-18 4:32 pm Purchase |
2020-09-17 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
56,377,388 57.600% |
8,773,969 (+18.43%) |
Filing History |
| 2020-09-04 5:29 pm Purchase |
2020-09-04 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
47,603,419 54.200% |
380,000 (+0.80%) |
Filing History |
| 2020-05-14 7:24 pm Purchase |
2020-05-12 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
47,223,419 62.100% |
8,773,969 (+22.82%) |
Filing History |